These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 38419027)
1. Limited utility of adding 3T cervical spinal cord MRI to monitor disease activity in multiple sclerosis. Lim TRU; Kumaran SP; Suthiphosuwan S; Espiritu AI; Jones A; Lin AW; Oh J; Bharatha A Mult Scler; 2024 Apr; 30(4-5):505-515. PubMed ID: 38419027 [TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis lesions and atrophy in the spinal cord: Distribution across vertebral levels and correlation with disability. Bussas M; El Husseini M; Harabacz L; Pineker V; Grahl S; Pongratz V; Berthele A; Riederer I; Zimmer C; Hemmer B; Kirschke JS; Mühlau M Neuroimage Clin; 2022; 34():103006. PubMed ID: 35468568 [TBL] [Abstract][Full Text] [Related]
3. The added value of spinal cord lesions to disability accrual in multiple sclerosis. Ruggieri S; Prosperini L; Petracca M; Logoteta A; Tinelli E; De Giglio L; Ciccarelli O; Gasperini C; Pozzilli C J Neurol; 2023 Oct; 270(10):4995-5003. PubMed ID: 37386292 [TBL] [Abstract][Full Text] [Related]
4. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord. Eden D; Gros C; Badji A; Dupont SM; De Leener B; Maranzano J; Zhuoquiong R; Liu Y; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Bannier E; Kerbrat A; Edan G; Labauge P; Callot V; Pelletier J; Audoin B; Rasoanandrianina H; Brisset JC; Valsasina P; Rocca MA; Filippi M; Bakshi R; Tauhid S; Prados F; Yiannakas M; Kearney H; Ciccarelli O; Smith SA; Andrada Treaba C; Mainero C; Lefeuvre J; Reich DS; Nair G; Shepherd TM; Charlson E; Tachibana Y; Hori M; Kamiya K; Chougar L; Narayanan S; Cohen-Adad J Brain; 2019 Mar; 142(3):633-646. PubMed ID: 30715195 [TBL] [Abstract][Full Text] [Related]
5. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis. Brownlee WJ; Altmann DR; Prados F; Miszkiel KA; Eshaghi A; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O Brain; 2019 Aug; 142(8):2276-2287. PubMed ID: 31342055 [TBL] [Abstract][Full Text] [Related]
6. Spinal cord MRI activity in multiple sclerosis: Predictive value for relapses and impact on treatment decisions. Lorefice L; Piras C; Sechi V; Barracciu MA; Cocco E; Fenu G J Neurol Sci; 2024 Jul; 462():123057. PubMed ID: 38820738 [TBL] [Abstract][Full Text] [Related]
7. The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRI. Di Sabatino E; Gaetani L; Sperandei S; Fiacca A; Guercini G; Parnetti L; Di Filippo M J Neurol; 2022 Jun; 269(6):3129-3135. PubMed ID: 34820734 [TBL] [Abstract][Full Text] [Related]
8. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis. Barro C; Benkert P; Disanto G; Tsagkas C; Amann M; Naegelin Y; Leppert D; Gobbi C; Granziera C; Yaldizli Ö; Michalak Z; Wuerfel J; Kappos L; Parmar K; Kuhle J Brain; 2018 Aug; 141(8):2382-2391. PubMed ID: 29860296 [TBL] [Abstract][Full Text] [Related]
9. Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis. Cortese R; Tur C; Prados F; Schneider T; Kanber B; Moccia M; Wheeler-Kingshott CAG; Thompson AJ; Barkhof F; Ciccarelli O Mult Scler; 2021 Jan; 27(1):28-38. PubMed ID: 31961242 [TBL] [Abstract][Full Text] [Related]
12. Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis. Dekker I; Sombekke MH; Witte BI; Geurts JJ; Barkhof F; Uitdehaag BM; Killestein J; Wattjes MP Mult Scler; 2018 Apr; 24(4):481-490. PubMed ID: 29106327 [TBL] [Abstract][Full Text] [Related]
13. The impact of cervical spinal cord atrophy on quality of life in multiple sclerosis. Zurawski J; Glanz BI; Healy BC; Tauhid S; Khalid F; Chitnis T; Weiner HL; Bakshi R J Neurol Sci; 2019 Aug; 403():38-43. PubMed ID: 31207364 [TBL] [Abstract][Full Text] [Related]
14. Spinal cord lesions are frequently asymptomatic in relapsing-remitting multiple sclerosis: a retrospective MRI survey. Granella F; Tsantes E; Graziuso S; Bazzurri V; Crisi G; Curti E J Neurol; 2019 Dec; 266(12):3031-3037. PubMed ID: 31494713 [TBL] [Abstract][Full Text] [Related]
15. The course of cervical spinal cord atrophy rate and its relationship with NEDA in relapsing remitting multiple sclerosis. Cilingir V; Akdeniz H Acta Neurol Belg; 2022 Apr; 122(2):345-355. PubMed ID: 33475987 [TBL] [Abstract][Full Text] [Related]
16. Selective vulnerability of brainstem and cervical spinal cord regions in people with non-progressive multiple sclerosis of Black or African American and European ancestry. Okuda DT; Stanley T; McCreary M; Smith A; Wilson A; Pinho MC; Yu FF; Billiet T; Van Hecke W; Ribbens A; Zeydan B; Kantarci O; Guo X; Moog TM Mult Scler; 2023 May; 29(6):691-701. PubMed ID: 36507671 [TBL] [Abstract][Full Text] [Related]
17. Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis. Bonacchi R; Pagani E; Meani A; Cacciaguerra L; Preziosa P; De Meo E; Filippi M; Rocca MA Radiology; 2020 Sep; 296(3):605-615. PubMed ID: 32573387 [TBL] [Abstract][Full Text] [Related]